Detalles de la búsqueda
1.
The Inhibitors of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT-1) Protease as Potential Treatment of ABC-DLBCL and Similar Diseases.
ACS Med Chem Lett
; 15(6): 763-765, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38894907
2.
Somatostatin Receptor Subtype 4 Agonists for Potential Treatment of Alzheimer's Disease and Other Central Nervous System Disorders.
ACS Med Chem Lett
; 15(6): 766-768, 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38894906
3.
Inhibitors of Son of Sevenless Isoform 1 (SOS1) as a Potential Treatment for RAS Mutant Cancers.
ACS Med Chem Lett
; 15(1): 9-11, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229747
4.
Positive Allosteric Modulators of alpha7 Nicotinic Acetylcholine Receptor for the Treatment of Several Central Nervous System Diseases.
ACS Med Chem Lett
; 15(1): 6-8, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38229741
5.
Inhibitors of Interleukin 4 Induced Protein 1 (IL4I1) as Potential Treatment for Cancer.
ACS Med Chem Lett
; 14(2): 127-128, 2023 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793430
6.
Plasma Kallikrein Inhibitors as Potential Treatment for Diabetic Macular Edema, Retinal Vein Occlusion, Hereditary Angioedema and Other Related Diseases.
ACS Med Chem Lett
; 14(2): 129-130, 2023 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793429
7.
The Potential of NOD-like Receptor Protein 3 Inflammasome Inhibitors in the Treatments of Diseases.
ACS Med Chem Lett
; 14(10): 1323-1325, 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37849533
8.
Targeting the Inhibition of B-Cell Lymphoma 2 Protein for the Treatment of Cancer.
ACS Med Chem Lett
; 14(10): 1320-1322, 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37849546
9.
Orexin Receptor Agonists as Possible Treatment for Narcolepsy and Idiopathic Hypersomnia.
ACS Med Chem Lett
; 13(9): 1411-1412, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105332
10.
Combination of Cyclin-Dependent Kinase 4 Inhibitors and Androgen Receptor Inhibitors as Cancer Therapy.
ACS Med Chem Lett
; 13(9): 1408-1410, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105336
11.
Inhibitors of Transforming Growth Factor Beta Receptor 1 (TGFßr1) May Enhance the Efficacy of Several Monoclonal Antibodies as Cancer Therapy.
ACS Med Chem Lett
; 13(9): 1405-1407, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105341
12.
Therapeutic Potential of Monoacylglycerol Lipase (MGL) Inhibitors as Treatment for Pain, Depression, Cancers, and Eye Conditions.
ACS Med Chem Lett
; 13(1): 22-24, 2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059118
13.
The Inhibitors of Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) as Potential Enhancers of Cancer Immunotherapy and Type 1 (PTPN1) as Treatment of Metabolic Diseases.
ACS Med Chem Lett
; 13(1): 19-21, 2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059117
14.
Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases.
ACS Med Chem Lett
; 12(12): 1889-1891, 2021 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34917248
15.
Adenosine Receptor Antagonists as Potential Cancer Therapy.
ACS Med Chem Lett
; 12(12): 1892-1893, 2021 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34917249
16.
The Potential of c-KIT Kinase inhibitors in Cancer Treatment.
ACS Med Chem Lett
; 12(8): 1191-1192, 2021 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413937
17.
Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists May Provide a Superior Treatment for Pain and Migraine.
ACS Med Chem Lett
; 12(8): 1193-1195, 2021 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413938
18.
Cannabinoid Receptor Agonists for the Potential Treatment of Pain, Neurological Disorders, Fibrotic Diseases, Obesity, and Many More.
ACS Med Chem Lett
; 12(8): 1188-1190, 2021 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413936
19.
Potential of Cyclin-Dependent Kinase Inhibitors as Cancer Therapy.
ACS Med Chem Lett
; 12(2): 182-184, 2021 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603963
20.
Reactivation of the Guardian of the Genome P53: A Promising Strategy for Treatment of Cancer.
ACS Med Chem Lett
; 12(3): 331-333, 2021 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33738057